A NON-INTERVENTIONAL OBSERVATIONAL STUDY ASSESSING SAFETY OF DEFERASIROX IN PATIENTS WITH HEMOGLOBINOPATHIES AND TRANSFUSIONAL IRON OVERLOAD: RESULTS FROM THE "ENERGY" STUDY

被引：0

作者：

Voskaridou, E. ^{[1
]}

Dimopoulou, M. ^{[1
]}

Drosou, M. ^{[2
]}

Vini, D. ^{[2
]}

Ladis, V. ^{[3
]}

Kattamis, A. ^{[3
]}

Economou, M. ^{[4
]}

Vlachaki, E. ^{[5
]}

Symeonidis, A. ^{[6
]}

Kouraklis, A. ^{[6
]}

Dimitriadou, E. ^{[7
]}

Kapsali, E. ^{[8
]}

Chatziliami, A. ^{[9
]}

Fragodimitri, C. ^{[9
]}

Lafioniatis, S. ^{[10
]}

Karavas, A. ^{[11
]}

Klironomos, E. ^{[12
]}

Aggelaki, M. ^{[13
]}

Calpaka, A. ^{[13
]}

Kontogianni, K. ^{[14
]}

Michos, A. ^{[15
]}

Papageorgiou, U. ^{[16
]}

Lafiatis, I. ^{[17
]}

Adamopoulos, I. ^{[18
]}

机构：

[1] Laiko Univ, Gen Hosp Athens, Thalassemia Ctr, Athens, Greece

[2] Gen Hosp Agios Panteleimon Nikea, Piraeus, Greece

[3] Univ Athens, Agia Sofia Childrens Hosp, Thalassemia Unit, Dept Pediat 1, Athens, Greece

[4] Aristotle Univ Thessaloniki, Thalassaemia Unit, Paediat Dept 1, Hippokrat Gen Hosp Thessaloniki, GR-54006 Thessaloniki, Greece

[5] Hippokrateon Hosp, Adult Thalassemia Unit, Dept Internal Med 2, Thessaloniki, Greece

[6] Univ Patras, Sch Med, Dept Internal Med, Div Hematol, GR-26110 Patras, Greece

[7] Gen Hosp Trikala, Trikala, Greece

[8] Ioannina Univ Hosp, Thalassemia Unit, Dept Clin Hematol, Ioannina, Greece

[9] Childrens Hosp Athens Agia Sofia, Athens, Greece

[10] Gen Hosp Achilopouleio Volos, Volos, Greece

[11] Drakopouleio Blood Ctr Athens, Athens, Greece

[12] Venizel Gen Hosp Heraklion, Thalassaemia Unit, Iraklion, Greece

[13] Gen Hosp Agios Pavlos Thessaloniki, Thessaloniki, Greece

[14] Univ Hosp Larissa, Larisa, Greece

[15] Gen Hosp Corfu, Thalassaemia Unit, Corfu, Greece

[16] Karamandaneio Childrens Hosp, Patras, Greece

[17] Gen Hosp Vostanio Mytilini, Mitilini, Greece

[18] Gen Hosp Kalamata, Kalamata, Greece

来源：

HAEMATOLOGICA | 2015年 / 100卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

E1473

引用

页码：590 / 591

页数：2

共 50 条

[1] Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional study
Nolte, Florian
Nueckel, Holger
Schmidt, Burkhard
Geer, Thomas
Rubanov, Oleg
Hebart, Holger
Jarisch, Andrea
Albrecht, Stefan
Johr, Christiane
Schumann, Christiane
Hofmann, Wolf-Karsten
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (08) : 1531 - 1538
[2] Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional study
Florian Nolte
Holger Nückel
Burkhard Schmidt
Thomas Geer
Oleg Rubanov
Holger Hebart
Andrea Jarisch
Stefan Albrecht
Christiane Johr
Christiane Schumann
Wolf-Karsten Hofmann
Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1531 - 1538
[3] CONIFER - Non-Interventional Study to Evaluate Therapy Monitoring During Deferasirox Treatment of Iron Toxicity in Myelodysplastic Syndrome Patients with Transfusional Iron Overload
Bruch, Harald-Robert
Dencausse, Yves
Hessling, Joerg
Michl, Gerlinde
Schlag, Rudolf
Skorupa, Alexandra
Schneider-Schranz, Cornelia
Wolf, Sebastian
Schulte, Clemens
Tesch, Hans
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (7-8) : 424 - 431
[4] Deferasirox in the routine-treatment of MDS patients with chronic iron overload: interim results from the non-interventional, prospective study EXSEPT
Nolte, F.
Schumann, C.
Bueckner, U.
Schmidt, B.
Hebart, H.
Rubanov, O.
Kuehn, R-B
Kreil, S.
Metzgeroth, G.
Johrs, C.
Albrecht, S.
Bach, T.
Hofmann, W-K
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 60 - 60
[5] CONIFER - Non-interventional study to evaluate therapy monitoring during Exjade® (Deferasirox) treatment of iron toxicity in MDS patients with transfusional iron overload in the course of treatment
Tesch, H.
Bruch, H. -R.
Denacausse, Y.
Hessling, J.
Lerchenmueller, C.
Michel, G.
Schlag, R.
Skoruba, A.
Schneider-Schranz, C.
Wolf, S.
Schulte, C.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 116 - 116
[6] Efficacy and safety of deferasirox in routine clinical management of transfusion-dependent patients with iron overload - interim analysis of the non-interventional study EXSEPT
Schumann, C.
Nolte, F.
Rubanov, O.
Kuehn, R-B
Kreil, S.
Metzgeroth, G.
Junkes, A.
Johr, C.
Albrecht, S.
Hofmann, W-K
ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 78 - 78
[7] MANAGEMENT OF IRON OVERLOAD WITH DEFERASIROX IN VARIOUS HEMATOLOGICAL MALIGNANCIES - REAL WORLD EXPERIENCES FROM THE GERMAN NON-INTERVENTIONAL STUDY EXSEPT
Nolte, F.
Schumann, C.
Nueckel, H.
Schmidt, B.
Hebart, H.
Rubanov, O.
Kuehn, R.
Kreil, S.
Metzgeroth, G.
Johr, C.
Albrecht, S.
Hofmann, W.
HAEMATOLOGICA, 2016, 101 : 244 - 244
[8] EFFICACY, EFFICIENCY AND SAFETY OF DEFERASIROX FOR TREATING TRANSFUSIONAL IRON OVERLOAD IN NON-ACTIVELY TRANSFUSED PATIENTS
Kattamis, A.
Lazopoulou, N.
Rigatou, E.
Kostaridou, S.
Lourida, A.
Ladis, V.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 513 - 513
[9] TREATMENT WITH DEFERASIROX FOR NON-TRANSFUSIONAL IRON OVERLOAD IN PATIENTS WITH THALASSEMIA INTERMEDIA
Ladis, V.
Berdoussi, H.
Kattamis, A.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 509 - 509
[10] Impact of Age and Type of Underlying Disease on Long-Term Safety and Efficacy in Patients with Transfusional Hemosiderosis Treated with Deferasirox: Results from a 3-Year Non-Interventional Study (SENTINEL)
Elalfy, Mohsen
Inusa, Baba
Beneitez, David
Xicoy, Blanca
Nieto, Maria Soledad Duran
Bruederle, Andreas
Azmon, Amin
El-Beshlawy, Amal
BLOOD, 2016, 128 (22)

← 1 2 3 4 5 →